t(15;17)(q24;q21)

Cidegen

Delivery time

<1 week

Sample

Blood. Biopsy tissue. Bone marrow

166,98€

A characteristic alteration of Acute Promyelocytic Leukemia (present in more than 90% of cases). Generally characterized by the t(15;17) translocation that generates the PML::RARA fusion gene. Depending on the breakpoint in PML, different transcripts are distinguished, the most frequent being bcr1, bcr2, and bcr3. Treatment with ATRA and ATO.

Other tests

Trisomy 11 (Blood. Biopsy tissue)

Trisomy 11 (Blood. Biopsy tissue)

166,98€

Trisomy 11 (Blood. Biopsy tissue. Bone marrow)

Trisomy 11 (Blood. Biopsy tissue. Bone marrow)

166,98€

Sequencing of exons 9, 11, 13 and 14 of the POLE gene. (Analysis in biopsy tissue)

Sequencing of exons 9, 11, 13 and 14 of the POLE gene. (Analysis in biopsy tissue)

932,31€